Showing 1 - 20 results of 143 for search 'extensive treating program', query time: 0.15s Refine Results
  1. 1

    HMOVG: An Interactive Computer Program Based on the Huckel Molecular Orbital Model and Making an Extensive Use of Graphic Facilities by Michel Roch, Jean-Jacques Combremont, Jacques Weber

    Published 1982-04-01
    “… HMOVG (Hückel Molecular Orbital Vector General) is basically a Hückel Molecular Orbital (HMO) program making an extensive use of interactive graphic facilities provided by a calligraphic display system. …”
    Get full text
    Article
  2. 2

    Relapsed Chronic Lymphocytic Leukaemia with Concomitant Extensive Chronic Graft versus Host Disease after Allogeneic Haematopoietic Stem Cell Transplantation Successfully Treated w... by Ching Soon Teoh, Ai Sim Goh

    Published 2021-01-01
    “…The relapsed CLL was treated successfully with oral venetoclax accessible via a compassionate drug program. …”
    Get full text
    Article
  3. 3
  4. 4
  5. 5

    A decade of antimicrobial resistance trends in Pseudomonas aeruginosa: insights from a tertiary care hospital in Saudi Arabia (2013–2022) by Yahya Shabi, Abdullah Algarni, Ali Al bshabshe, Tarik Alazraqi, Glenn Patriquin, Abdulah OS Bawazeer, Safia Abdullah Mohammed, Sara Habbash, Ali Somily, Abdulah J. Alqahtani, Saeed M. S. Alhamhhum

    Published 2025-07-01
    “…Carbapenem resistance was observed in 40% of isolates; 37.5% were multidrug-resistant (MDR), 5.3% were extensively drug-resistant (XDR), and 3.5% met the criteria for difficult-to-treat resistance (DTR).ConclusionThis study provides an overview of PA resistance pattern trends in Saudi Arabia and emphasizes the importance of establishing an antimicrobial stewardship program.…”
    Get full text
    Article
  6. 6

    Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection by Rosie Mngqibisa, Huichao Chen, Catherine Godfrey, Motshedisi Sebitloane, Unoda Chakalisa, Sharlaa Badal-Faesen, Gaerolwe Masheto, Frank Taulo, Wadzanai Samaneka, Jennifer Tiu, Cynthia Firnhaber, Timothy Wilkin, the AIDS Clinical Trials Group A5282 Study Team

    Published 2024-12-01
    “…This has implications for cervical cancer programs as these lesions can only be optimally treated with surgical therapies such as loop electroexcision procedures, and the capacity for this procedure should be increased to maximise cervical cancer prevention outcomes.…”
    Get full text
    Article
  7. 7

    Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline b... by Baiyang Huang, Senyuan Liu, Kaiyue Wang, Jiarui Zhao, Min Li, Xingpeng Wang, Weiqing Wang, Xiaohan Wang, Jinming Yu, Xue Meng, Guoxin Cai

    Published 2025-03-01
    “…Among these patients, 137 (63.4%) received first-line ICIs combined with chemotherapy (ChT), including 32 patients treated with anti-programmed death 1 antibody (αPD-1) and 105 patients treated with anti-programmed death-ligand 1 antibody (αPD-L1), and 79 patients (36.6%) received first-line ChT alone. …”
    Get full text
    Article
  8. 8

    Complete remission of a high-risk, locally advanced cervical cancer with para-aortic lymph node metastases treated with first-line tislelizumab plus bevacizumab combined with chemo... by Juan Lang, Juan Lang, Qianqian Liu, Rong Ji, Miao Qiu, Siben Wang, Qingmeng Liu, Dapeng Li, Ping Chen, Zhongkui Xiong, Zhongkui Xiong

    Published 2025-05-01
    “…Herein, we present a case of a newly diagnosed high-risk, locally advanced cervical cancer patient with PALN metastases and low PD-L1 expression, treated with a combination of tislelizumab, bevacizumab, and a platinum-containing chemotherapy regimen followed by radiotherapy with maintenance therapy, resulting in a notable extension of progression-free survival.…”
    Get full text
    Article
  9. 9
  10. 10
  11. 11

    The management of post-traumatic elbow extension deficit in the subacute phase: A case report series of four patients by Germaine Sim, Jennifer Fleming, Celeste Glasgow

    Published 2025-04-01
    “…All participants received 6 weekly therapy sessions which included a standardized home exercise program. Orthotic1-2 received additional extension orthoses which were remoulded each week according to progress. …”
    Get full text
    Article
  12. 12

    Comprehensive analysis of extensive drug-resistant Salmonella Typhi in Gujarat region, India: genomic findings and prospective alternative therapy by Sadanand Dangari Akshay, Heli Upadhyaya, Nitin Shukla, Rohit Bhattacharjee, Sunilkumar Das, Urmi Vyas, Priyank Chavda, Nimesh Patel, Dixsha Jamkhandi, Pritesh Sabara, Neeta Khandelwal, Sumeeta Soni, Kamlesh Upadhyaya, Jayesh Katira, Geeti Maheshwari, Madhvi Joshi, Devarshi Gajjar, Chaitanya Joshi

    Published 2025-07-01
    “…The Gujarat State Biotechnology Mission, Government of Gujarat, India, has funded the “Network Program on Antimicrobial Resistance, Superbugs, and One Health” to track antibiotic resistance patterns in the Gujarat region. …”
    Get full text
    Article
  13. 13

    Hereditary Painful Callosities Treated with L5 and S1 Pulsed Radiofrequency, Case Report by Moustafa Moustafa, Kenneth Kuan Boon Keat, Hari Gopal

    Published 2025-06-01
    “…We followed a holistic approach by enrolling him in the pain management program and Left L5 and S1 Pulsed Radiofrequency treatment at left L5 and S1 DRGs. …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16
  17. 17

    Abstract 247: Visual versus Computer Software Assessment of Perfusion in Anterior Circulation Stroke Treated with Mechanical Thrombectomy by Igor Rigler, Tina Gspan, Senta Frol, Janja Pretnar Oblak

    Published 2023-11-01
    “…As this method is simple and easy to use, it can be performed in almost any CT unit, even without a software program for CTP analysis or advanced subspecialized knowledge in neuroradiology.…”
    Get full text
    Article
  18. 18

    Thapsigargin triggers a non-apoptotic, caspase-independent programmed cell death in basophilic leukaemia cells by Philip Steiner, Korollus Melek, Ancuela Andosch, Lena Wiesbauer, Anna Madlmayr, Michelle Duggan, Hubert H. Kerschbaum, Susanna Zierler

    Published 2025-07-01
    “…These autosis-like features were also observed in TG-treated murine macrophages and human mast cells, suggesting a conserved mechanism across cell types. …”
    Get full text
    Article
  19. 19

    The Age-Dependent Increase of Metabolic Syndrome Requires More Extensive and Aggressive Non-Pharmacological and Pharmacological Interventions: A Cross-Sectional Study in an Italian... by Antonello E. Rigamonti, Sabrina Cicolini, Sofia Tamini, Diana Caroli, Silvano G. Cella, Alessandro Sartorio

    Published 2021-01-01
    “…At least in an Italian context of obese females, the age-dependent worsening of glycaemia and BP exerts a fundamental pathophysiological role in the progressive increase of metabolic syndrome with advancing age, which appears to be not adequately treated in a large part of obese subjects. The results of the present study might be useful for public health decision-makers for programming future more extensive and aggressive non-pharmacological and pharmacological interventions in the obese population.…”
    Get full text
    Article
  20. 20

    First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial by Ying Cheng, Shuang Zhang, Liang Han, Lin Wu, Jun Chen, Peiyan Zhao, Hongmei Sun, Guilan Wen, Yinghua Ji, Anastasia Zimina, Jianhua Shi, Zhijie Pan, Jinsheng Shi, Xicheng Wang, Yuansong Bai, Tamar Melkadze, Yueyin Pan, Xuhong Min, Maksym Viguro, Xingya Li, Yanqiu Zhao, Junquan Yang, Tamta Makharadze, Ekaterine Arkania, Haoyu Yu, Jing Li, Fang Yang, Xinyi Yang, Chen Ling, Qingyu Wang, Yongqiang Shan, Jun Zhu, the ASTRUM‐005 Study Group

    Published 2025-08-01
    “…Abstract Background The ASTRUM‐005 study previously demonstrated a significant overall survival (OS) benefit with serplulimab (a programmed death 1 inhibitor) plus chemotherapy versus chemotherapy alone in previously untreated extensive‐stage small‐cell lung cancer (ES‐SCLC). …”
    Get full text
    Article